BLACK WEEKSFlacons −15% · kits −10% · reste −5%avec le codeLivraison gratuite en Allemagne dès 200 €

Cette page a été traduite automatiquement et peut contenir des erreurs. Vous êtes de langue maternelle française ? Vos remarques et corrections sont les bienvenues.Envoyer un retour

The Peptide Desk The Peptide Desk
Thymosin Alpha-1, photo du produit

Rapport de laboratoire

PDF
99%
Pureté
Testé
Thymosin Alpha-1 5mg
Laboratoire
Analiza Białek
Date
November 2026
Résultat
99% purity (5.33 mg measured)
Endotoxines
4.56 EU/vial
N° de commande
Mot de passe

Testé de manière indépendante, vérifiable avec le mot de passe directement auprès du laboratoire.

Immune System

Thymosin Alpha-1

Immune System

Commande

Prix unitaire - Livraison gratuite en Allemagne dès 200 € pendant les Black Weeks
  • DHL avec suivi
  • Emballage discret

4.6 sur 5 sur Trustpilot73 avis

En un coup d'œil

Thymosin Alpha-1 en chiffres

Les chiffres clés de notre lexique.

Article complet du lexique
Class
Immune-modulating peptidethymus-derived
Frequency
~2x per weekin phases
Form
Lyophilised powderreconstituted with BAC water
Sizes
5 to 10 mg2 sizes in the shop

Connaissances

Tout sur Thymosin Alpha-1

Bon à avoir

Ce dont vous avez besoin avec

L'eau bactériostatique est ajoutée automatiquement à votre panier. Seringues et tampons en un clic.

Seringues à insuline

10 pièces · 5.50 €

Tampons alcoolisés

50 pièces · 10 €

Combien d'eau ?

Unités sur la seringue pour la taille de votre flacon.

Ouvrir le calculateur →

FAQ

Questions fréquentes

Sources pour chaque réponse : article du lexique

Encore une question ?

Écrivez-nous, notre équipe vous aidera.

Is Thymosin Alpha-1 approved?

Yes, but not everywhere. As thymalfasin it is approved in over 35 countries according to a 2009 review, mainly for hepatitis B and C and to strengthen the immune system. There is no approval in the US, ChEMBL lists the compound at phase 3.

How does Thymosin Alpha-1 work?

In cell and mouse experiments it made dendritic cells more active, the cells that show pathogens to the immune system. This ran via the receptor TLR9. At the same time it promoted regulatory T cells, which slow down excessive reactions. ChEMBL lists no confirmed mechanism in humans.

What do the sepsis trials show?

In ETASS with 361 people 26 percent died within 28 days with Thymosin Alpha-1 and 35 percent without, a difference that just missed certainty. The larger TESTS trial with 1,106 people and placebo found 23.4 versus 24.1 percent, so no difference. A possible benefit from age 60 counts only as a hint there.

Are there data on cancer?

In a trial with 488 people with advanced melanoma Thymosin Alpha-1 was added to chemo. The highest study dose was 6.4 mg. More tumours responded and median survival was 9.4 versus 6.6 months, but not statistically certain. There were no extra side effects.

Does it help in severe pancreatitis?

Not with certainty in the TRACE trial with 508 people. Infected dead tissue occurred in 15.7 percent with Thymosin Alpha-1 and 18.1 percent on placebo. The main goal was therefore not reached.

Which side effects are known?

In TESTS 66.4 percent on Thymosin Alpha-1 and 67.6 percent on placebo had an adverse event, serious events were 26.8 versus 29.3 percent. ETASS recorded no serious side effects caused by the drug. With autoimmune disease the regular entry advises restraint.

Produits associés

Produits similaires